Daniel R. McCallum

ID: 1b83c15e-2619-30fb-68c4

/

Claimed Record

/

Organization: Rothwell Figg

Litigation Spotlight Update: The Saga Continues: The Infliximab (Remicade®) Litigation

Biosimilars Law Bulletin · June 12, 2017

<i>Cascades Projection v. Epson</i> – Questioning the Constitutionality of IPRs

PTAB Law Blog · June 7, 2017

The Bounds of Procedural Due Process – <i>Intellectual Ventures II LLC v. Ericsson, Inc.</i>

PTAB Law Blog · May 11, 2017

The Patent Dance Goes on for Genentech and Amgen Over Bevacizumab (Avastin®)

Biosimilars Law Bulletin · April 20, 2017

Litigation Spotlight: The Infliximab (Remicade®) Litigation

Biosimilars Law Bulletin · April 19, 2017

Practice Areas

Health Care and Life Sciences

Intellectual Property

Jurisdictions

Washington, D.C.